2024 biotech funding tracker: recent highlights


With $700 million Q3 rise, U.K. biotech spearheads European recovery

Weekly Roundup 10 Nov 2023

Korro Bio and Frequency’s merger; Lexeo’s $100 million IPO; Gate Biosciences new class of drugs

BioTechX 2023: the highlights

In Depth 20 Oct 2023

Is Africa ready to become the next big biopharma and vaccine manufacturing destination?